NCT06696066

Brief Summary

The goal of this pilot study is to evaluate the feasibility and acceptability of implementing a peer recovery support program to support patient engagement in medication treatment for opioid use disorder (MOUD). The program, entitled "Promoting Enhanced Engagement through Recovery Support" (PEERS) was developed in collaboration with community and clinical partners for the MOUD outpatient setting. Information gathered during this pilot study will inform refinements to the program and study components for a future clinical trial that will evaluate the effectiveness of the peer recovery support program in increasing patient retention in MOUD. The investigators will recruit 12 participants to the pilot study, all of whom will receive the PEERS program. The study will take place in Geisinger outpatient addiction treatment clinics in northeast Pennsylvania. Patients initiating MOUD treatment at one of the clinics will be eligible for participation, and will be recruited via email, patient portal messages, and phone. Each participant will receive the PEERS program, entailing regular sessions with a Certified Recovery Specialist (CRS) for 6 months. Participants will also be asked to complete assessments at baseline and 12 weeks and will be invited to provide qualitative feedback on their experience with the program through an interview conducted between 8-12 weeks. As the focus of the pilot pertains to the feasibility and acceptability of the program and the study components, study outcomes focus on participant engagement in and acceptance of the program, CRS fidelity to the program, barriers to implementation, and feasibility of data collection.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
13

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 18, 2024

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 19, 2024

Completed
3 months until next milestone

Study Start

First participant enrolled

February 18, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 9, 2025

Completed
24 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 3, 2025

Completed
8 months until next milestone

Results Posted

Study results publicly available

February 25, 2026

Completed
Last Updated

February 25, 2026

Status Verified

February 1, 2026

Enrollment Period

4 months

First QC Date

November 18, 2024

Results QC Date

February 3, 2026

Last Update Submit

February 20, 2026

Conditions

Keywords

Opioid Use Disorder

Outcome Measures

Primary Outcomes (2)

  • Feasibility - Participant Engagement in the Peer Recovery Support Program

    Percent of participants who attended at least 2 sessions with the Certified Recovery Specialist

    Baseline to 12 weeks

  • Acceptability - Participant Alliance With Certified Recovery Specialist

    Participants' average scores for the Scales for Participant Alliance with Recovery Coach (SPARC-2); score can range from 1-5 and a high score indicates greater satisfaction with the CRS.

    12 weeks

Secondary Outcomes (2)

  • Feasibility - Feasibility of Assessment Completion

    Baseline

  • Feasibility - Feasibility of Assessment Completion

    12 weeks

Study Arms (1)

Peer Recovery Support Pilot Program Implementation and Assessment

EXPERIMENTAL

Participants will be offered services from a certified recovery specialist (CRS; i.e., the Peer Recovery Support program). This will entail a CRS meeting one-on-one with the patient at regular intervals (e.g., weekly) to provide support to the participant for a 6-month period. CRS services are patient-centered and driven by a patient's own recovery goals, thus the frequency, timing, duration, modality (in-person, phone), and location of meetings (in the clinic or in a community setting such as a coffeeshop) are flexible and determined collaboratively by the CRS and patient.

Behavioral: PRS Program

Interventions

PRS ProgramBEHAVIORAL

The Peer Recovery Support program will be delivered by a certified recovery specialist (CRS) over the course of 6-months. The CRS will provide supportive care to the participant during their initial 6-months of MOUD treatment to increase patient engagement in their treatment. The CRS may provide emotional support; help participants to identify their recovery assets, goals, and barriers; guide participants in creating a recovery plan; help participants to increase their coping skills; and assist participants in connecting to community and recovery resources.

Peer Recovery Support Pilot Program Implementation and Assessment

Eligibility Criteria

Age18 Years - 89 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult ≥ 18 years of age
  • Initiated medication for opioid use disorder at a Geisinger outpatient addiction treatment clinic within the past 45 days
  • Willing to participate in the Peer Recovery Support program
  • Able and willing to provide consent

You may not qualify if:

  • Received medication for opioid use disorder at a Geisinger outpatient addiction treatment clinic in the 90 days prior to the treatment initiation date
  • Not proficient in English

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Geisinger Health

Danville, Pennsylvania, 17822, United States

Location

MeSH Terms

Conditions

Opioid-Related Disorders

Condition Hierarchy (Ancestors)

Narcotic-Related DisordersSubstance-Related DisordersChemically-Induced DisordersMental Disorders

Results Point of Contact

Title
Dr. Melissa Poulsen
Organization
Geisinger

Study Officials

  • Melissa Poulsen, PhD

    Geisinger Clinic

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 18, 2024

First Posted

November 19, 2024

Study Start

February 18, 2025

Primary Completion

June 9, 2025

Study Completion

July 3, 2025

Last Updated

February 25, 2026

Results First Posted

February 25, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Locations